Huiyu has been selling high-quality anti-cancer generic injectables to more than 1,000 overseas medical facilities since 2015.

Huiyu offers over 81 generic products focusing on anti-cancer therapeutic area. Our manufacturing capabilities offer multiple dosage forms including immediate and modified release tablets and capsules, soft gel capsules, gels, oral liquids and injectables.

The companies we work with rely on us for pharmaceutical intellectual property. This intellectual property comes in the form of registration dossiers which must meet regulations and guidelines.

Our experience and skills in launching new products and navigating regulations help us achieve quick and successful outcomes.  We have established business partners in more than 90 countries worldwide with approved and ongoing products’ registrations. Our products have been supplying to over 30 countries and regions.  We are open to out-licensing Huiyu Pharma’s own generic products and candidates to partners worldwide.

Finally, we are continuing seeking partners worldwide for co-development and strategic alliances for generic drugs and innovative drugs in therapeutic areas of Liver cancer, pancreatic cancer, TNBC, gastric cancer, esophageal cancer, colorectal cancer, endometrial cancer, cervical cancer, pain (cancer pain); atopic dermatitis, vitiligo, psoriasis; postpartum, depression; gout; cachexia, etc.

If you are interested in partnering with us through in & out-licensing arrangement, please Contact Us .